This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Tremblay E, Tardif M. Usage optimal à long terme des inhibiteurs de la pompe à protons. [Optimal long-term use of proton pump inhibitors] Quebec: Institut national d'excellence en sante et en services sociaux (INESSS). 2016
Upon gathering information from good clinical practice recommendations and during multiple consultations, INESSS made the following observations:
• Prescribing PPIs is unwarranted in many cases.
• It will take more than clinical tools and training to change prescribing habits.
• One of the options for implementing the recommendations concerning the coverage of long-term PPI therapy could constitute a strategy for improving PPI use.
• The RAMQ confirms the feasibility of linking INESSS's clinical recommendations to one of the options for implementing the recommendations concerning PPI coverage in order to better guide PPI prescribing.
Subject indexing assigned by CRD
Humans; Lansoprazole; Proton Pump Inhibitors
Country of organisation
An English language summary is available.
Address for correspondence
Institut national d'excellence en santé et en services sociaux (INESSS), 1195 avenue Lavigerie, bureau 60 Québec (Québec) Canada, G1V 4N3
Date abstract record published